- John Hardy awarded 2015 Robert A. Pritzker Prize for Leadership in Parkinson's Research
- Video: Advances in Genetic Understanding of Parkinson's Disease
- GCH1 gene and Parkinson's risk
- The new Leonard Wolfson Experimental Neurology Centre (LWENC) has opened for clinical studies and trials
- LRRK2 and autophagy in fibroblasts
- LRRK2 and autophagy
- GBA and mitochondria
- Alpha-synuclein in LRRK2 brains
- α-Synucleinopathy associated with G51D SNCA mutation: A link between Parkinson’s disease and multiple system atrophy?
- Video: Parkinson's and the Genetic Revolution: From Genes to Treatments
- Public lecture: The autophagy signaling network, c-‐myc and pathology: don't mess with the cell cycle!
- Video: Brain Disease Research - Keeping You You
- Video: Degenerating Brains public symposium
- Mutations in VCP gene implicated in a number of neurodegenerative diseases
- Public lectures: new research into Alzheimer's, Parkinson's and Motor Neuron Disease
- Blog: Degenerating neurons
- Global research team discovers new Alzheimer’s risk gene
- Direct Observation of the Interconversion of Normal and Toxic Forms of a-Synuclein
- Video: The genetics of LRRK2 by Nick Wood
- Video: Parkinson's UK site visit for the Targeting LRRK2 project
- Successes of Deep Brain Stimulation for patients with Parkinson's disease
- Recordings in Parkinson's disease patients reveal details of communication between deep and superficial brain structures
- Five new Parkinson's genes identified
One of the UK Parkinson's Disease Consortium Principal Investigators, Prof John Hardy, has been awarded the 2015 Robert A. Pritzker Prize for his leadership in Parkinson's genetics research. The award was presented by Michael J. Fox at a ceremony in New York on April 15. From the Michael J. Fox Foundation website: More...
Webcast of the presentation entitled ‘Advances in Genetic Understanding of Parkinson's Disease’ given by Nicholas Wood (University College London, United Kingdom) presented at the Biochemical Society Hot Topic event, PINK1-Parkin Signalling in Parkinson’s Disease and Beyond, held in December 2014. More...
A study published in Brain, led by researchers
at UCL Institute of Neurology, has shown that genetic mutations which
cause a decrease in dopamine
production in the brain and lead to a form of childhood-onset Dystonia,
also play a role in the development of Parkinson’s disease.
The new Leonard Wolfson Experimental Neurology Centre (LWENC) has opened for clinical studies and trials
In this paper Claudia Manzoni studies how fibroblast
cells from people with Parkinson’s disease caused by mutations in LRRK2
react to starvation. Although the changes are quite subtle, there are
differences between the way that fibroblasts that contain mutant LRRK2
respond to being starved – suggesting that there may be changes in the
way that these cells regulate a key process called autophagy (a term
which comes from the greek meaning to eat yourself, and is one of the
ways that cells get rid of waste and recycle proteins and organellles).
Successes of Deep Brain Stimulation for patients with Parkinson's disease
15 April 2011
A team, led by Dr Tom Foltynie, from UCL Institute of Neurology’s Unit of Functional Neurosurgery recently published a study in the Journal of Neurology, Neurosurgery and Psychiatry, highlighting the positive results of Subthalamic Nucleus Deep Brain Stimulation (STN DBS) surgery on patients with Parkinson’s disease. Specifically the study looked at the outcome of 79 consecutive patients who underwent the surgery at the National Hospital of Neurology and Neurosurgery, Queen Square, showing that the surgery was both safe and beneficial to Parkinson’s patients.
The team demonstrated that at their 12 month follow-up visits, patients' symptoms and signs of Parkinson's had improved by 55% compared with their disability at start of the study. These figures compare favourably with all previously published series of STN DBS studies and justify the novel approach used by the researchers – that of “magnetic resonance image guided targeting." This approach allows researchers to ensure that electrodes are placed precisely and accurately using only a single trajectory through each hemisphere of the patient's brain.
Most importantly the team showed that by using this approach, the safety of performing STN DBS at Queen Square is second to none as not a single patient experienced any form of haemorrhage within the brain. An editorial accompanying this paper written by Professor Paul Krack in Grenoble, France described these data as "a new Benchmark in STN DBS".
Acknowledgements: The Unit of Functional Neurosurgery at the UCL-IoN is supported by the Parkinson Appeal and the Edmond J. Safra Philanthropic Foundation
Image: The team at the Unit of Functional Neurosurgery
Media Contact: Alison Brindle
Page last modified on 15 apr 11 15:57